Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Mar;79(3):328–334. doi: 10.1111/j.1365-2249.1990.tb08091.x

Molecular size heterogeneity of immunoglobulins in health and disease.

P J Roberts-Thomson 1, K Shepherd 1
PMCID: PMC1534949  PMID: 2317941

Abstract

The molecular size of serum IgG, IgA and IgM in patients with a variety of monoclonal and polyclonal immune disorders has been determined by a sensitive immunoblotting technique. IgM, IgA and IgG3 paraproteins from patients with B cell lymphoproliferative disorders frequently polymerize with IgA paraproteins demonstrating two polymeric series, the basic unit of the more dominant series being monomeric IgA, and the second consists of a basic unit having a molecular mass of approximately 70 kD heavier than monomeric IgA. The molecular nature of this heavier IgA moiety was shown to be IgA covalently bound with a single molecule of serum albumin or alpha 1 antitrypsin and this moiety was also observed in small quantities in sera from healthy subjects. IgM paraproteins, particularly from patients with malignant lymphoproliferative disorders, consisted of varying proportions of decamers, pentamers and monomers together with other low molecular weight IgM oligomers. Paraproteins from patients with benign conditions showed less tendency to exist in multiple molecular weight forms. Serum immunoglobulins from patients with polyclonal immune disorder also showed molecular sized heterogeneity. Significantly increased levels of dimeric IgA were observed in patients with alcoholic cirrhosis and Felty's syndrome, while low molecular weight IgM was commonly seen in patients with autoimmune disorders. In these latter disorders monomeric IgM correlated significantly with the serum IgM level suggesting a disorder of assembly of the IgM subunits during an ongoing IgM immune response. We have demonstrated considerable molecular size heterogeneity of serum immunoglobulins both in health and disease and have indicated some possible clinical associations.

Full text

PDF
328

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bush S. T., Swedlund H. A., Gleich G. J. Low molecular weight IgM in human sera. J Lab Clin Med. 1969 Feb;73(2):194–201. [PubMed] [Google Scholar]
  2. Carter P. M., Hobbs J. R. Clinical significance of 7s IgM in monoclonal IgM diseases. Br Med J. 1971 May 1;2(5756):260–261. doi: 10.1136/bmj.2.5756.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis A. C., Shulman M. J. IgM--molecular requirements for its assembly and function. Immunol Today. 1989 Apr;10(4):118–128. doi: 10.1016/0167-5699(89)90244-2. [DOI] [PubMed] [Google Scholar]
  4. Delacroix D. L., Elkom K. B., Geubel A. P., Hodgson H. F., Dive C., Vaerman J. P. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest. 1983 Feb;71(2):358–367. doi: 10.1172/JCI110777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grey H. M., Abel C. A., Yount W. J., Kunkel H. G. A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains. J Exp Med. 1968 Dec 1;128(6):1223–1236. doi: 10.1084/jem.128.6.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harisdangkul V., Barnes T. Y., Songcharoen S., Pennebaker J. B. Clinical significance of low molecular weight IgM in patients with systemic lupus erythematosus. J Rheumatol. 1984 Oct;11(5):638–643. [PubMed] [Google Scholar]
  7. Harries R., Beckman I., Roberts-Thomson P. Low molecular weight IgM. Detection using immunoblotting. J Immunol Methods. 1986 Apr 3;88(1):97–100. doi: 10.1016/0022-1759(86)90056-6. [DOI] [PubMed] [Google Scholar]
  8. Johns P., Stanworth D. R. A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes. J Immunol Methods. 1976 Mar;10(2-3):231–252. doi: 10.1016/0022-1759(76)90174-5. [DOI] [PubMed] [Google Scholar]
  9. Jones D. N., Koh L. Y., Bertouch J. V., Roberts-Thomson P. J. In vitro synthesis of low molecular weight IgM in rheumatoid arthritis. Arthritis Rheum. 1985 Jan;28(1):112–117. doi: 10.1002/art.1780280120. [DOI] [PubMed] [Google Scholar]
  10. Kalsi J., Delacroix D. L., Hodgson H. J. IgA in alcoholic cirrhosis. Clin Exp Immunol. 1983 Jun;52(3):499–504. [PMC free article] [PubMed] [Google Scholar]
  11. Mestecky J., Preud'homme J. L., Crago S. S., Mihaesco E., Prchal J. T., Okos A. J. Presence of J chain in human lymphoid cells. Clin Exp Immunol. 1980 Feb;39(2):371–385. [PMC free article] [PubMed] [Google Scholar]
  12. RATCLIFF P., SOOTHILL J. F., STANWORTH D. R. Physicochemical and immunological studies of pathological serum macroglobulins. Clin Chim Acta. 1963 Jan;8:91–108. doi: 10.1016/0009-8981(63)90204-3. [DOI] [PubMed] [Google Scholar]
  13. Roberts-Thomson P. J., Jones D. N., Koh L. Y., Neoh S. H., Thomas M., Bradley J. Low molecular weight IgM in B cell lymphoproliferative disorders. Aust N Z J Med. 1984 Apr;14(2):121–125. doi: 10.1111/j.1445-5994.1984.tb04273.x. [DOI] [PubMed] [Google Scholar]
  14. Roberts-Thomson P. J., Mason D. Y., MacLennan I. C. Relationship between paraprotein polymerization and clinical features in IgA myeloma. Br J Haematol. 1976 May;33(1):117–130. doi: 10.1111/j.1365-2141.1976.tb00978.x. [DOI] [PubMed] [Google Scholar]
  15. Roberts-Thomson P. J., Wernick R. M., Ziff M. Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum. 1981 Jun;24(6):795–802. doi: 10.1002/art.1780240607. [DOI] [PubMed] [Google Scholar]
  16. Roth R. A., Koshland M. E. Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly. J Biol Chem. 1981 May 10;256(9):4633–4639. [PubMed] [Google Scholar]
  17. Seligmann M., Mihaesco E., Hurez D., Mihaesco C., Preud'homme J. L., Rambaud J. C. Immunochemical studies in four cases of alpha chain disease. J Clin Invest. 1969 Dec;48(12):2374–2389. doi: 10.1172/JCI106204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Solomon A. Molecular heterogeneity of immunoglobulin-M (gammaM-globulin). J Immunol. 1969 Feb;102(2):496–506. [PubMed] [Google Scholar]
  19. Somer T. Rheology of paraproteinaemias and the plasma hyperviscosity syndrome. Baillieres Clin Haematol. 1987 Sep;1(3):695–723. doi: 10.1016/s0950-3536(87)80021-5. [DOI] [PubMed] [Google Scholar]
  20. Spiegelberg H. L., Fishkin B. G. Human myeloma IgA half-molecules. J Clin Invest. 1976 Nov;58(5):1259–1265. doi: 10.1172/JCI108580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Theofilopoulos A. N., Burtonboy G., LoSpalluto J. J., Ziff M. IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum. 1974 May-Jun;17(3):272–284. doi: 10.1002/art.1780170312. [DOI] [PubMed] [Google Scholar]
  22. Trascasa M. L., Egido J., Sancho J., Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol. 1980 Nov;42(2):247–254. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES